"Functional domain contributions to signaling specificity between the n" by Justin Matthew Summy

Semester

Fall

Date of Graduation

2001

Document Type

Dissertation

Degree Type

PhD

College

School of Medicine

Department

Microbiology, Immunology, and Cell Biology

Committee Chair

Daniel Flynn.

Abstract

c-Src and c-Yes are two widely expressed and highly homologous members of the Src family of non-receptor tyrosine kinases and are involved in a diverse range of cellular signaling pathways. They are frequently activated in human cancers, and thus represent potential targets for anti-tumor drug design. The high level of homology between these two kinases includes not only sequence similarity, but also overlapping regulation and function. Despite the redundancies between c-Src and c-Yes, however, specificity in signaling has been demonstrated between the two proteins. It was hypothesized in these studies that differences in the signaling capacities of c-Src and c-Yes could be attributed to functional domain differences. In order to test this hypothesis, chimeric proteins were created in which the SH4, Unique, SH3, or SH2 domains of c-Src or the constitutively activated Src527F, were replaced by those of c-Yes, either individually or in combinations. Differences in the signaling capacities of these proteins were assessed at the levels of protein/protein interactions, downstream gene induction, and cell biology. It was demonstrated that both the SH3 and SH2 domains were capable of directing differential protein/protein interactions between c-Src and c-Yes. While no differences in substrate selection were evident, the c-Yes SH3 domain failed to efficiently bind the Src SH3 binding partner AFAP-110 and several additional tyrosine-phosphorylated binding partners. Additionally, the c-Yes SH2 domain facilitated stable complex formation between Src527F/c-Yes chimeras and an unidentified 87 kDa tyrosine-phosphorylated protein, pp87. Differences in downstream gene induction and cell biology were mediated by the amino terminal region (including the SH4 and Unique domains), as Src527F/c-Yes amino terminal chimeras failed to induce efficient upregulation of Heme Oxygenase 1 expression and were unable to induce actin filament rearrangement or changes in cell morphology upon expression in chicken embryo fibroblasts. These results occurred concomitant with a failure of these chimeras to induce activation of the PI3K/Akt pathway and inactivation of RhoA. Taken together, these results indicate that each of the non-catalytic functional domains may contribute to signaling specificity between c-Src and c-Yes. These results may contribute to the overall knowledge of biological differences between c-Src and c-Yes and how Src family kinases in general are able to achieve signaling specificity.

Share

COinS